1-11273485-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_013319.3(UBIAD1):c.-47T>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0106 in 1,608,588 control chromosomes in the GnomAD database, including 1,439 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.054 ( 732 hom., cov: 31)
Exomes 𝑓: 0.0061 ( 707 hom. )
Consequence
UBIAD1
NM_013319.3 5_prime_UTR
NM_013319.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.822
Genes affected
UBIAD1 (HGNC:30791): (UbiA prenyltransferase domain containing 1) This gene encodes a protein thought to be involved in cholesterol and phospholipid metabolism. Mutations in this gene are associated with Schnyder crystalline corneal dystrophy. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 1-11273485-T-G is Benign according to our data. Variant chr1-11273485-T-G is described in ClinVar as [Benign]. Clinvar id is 291818.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.183 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UBIAD1 | NM_013319.3 | c.-47T>G | 5_prime_UTR_variant | 1/2 | ENST00000376810.6 | ||
UBIAD1 | NM_001330349.2 | c.-47T>G | 5_prime_UTR_variant | 1/3 | |||
UBIAD1 | NM_001330350.2 | c.-47T>G | 5_prime_UTR_variant | 1/2 | |||
UBIAD1 | XM_047418727.1 | c.-47T>G | 5_prime_UTR_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UBIAD1 | ENST00000376810.6 | c.-47T>G | 5_prime_UTR_variant | 1/2 | 1 | NM_013319.3 | P1 | ||
UBIAD1 | ENST00000376804.2 | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0541 AC: 8235AN: 152160Hom.: 726 Cov.: 31
GnomAD3 genomes
AF:
AC:
8235
AN:
152160
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0141 AC: 3417AN: 242416Hom.: 264 AF XY: 0.0109 AC XY: 1445AN XY: 132618
GnomAD3 exomes
AF:
AC:
3417
AN:
242416
Hom.:
AF XY:
AC XY:
1445
AN XY:
132618
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00608 AC: 8852AN: 1456310Hom.: 707 Cov.: 30 AF XY: 0.00531 AC XY: 3850AN XY: 724398
GnomAD4 exome
AF:
AC:
8852
AN:
1456310
Hom.:
Cov.:
30
AF XY:
AC XY:
3850
AN XY:
724398
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0543 AC: 8271AN: 152278Hom.: 732 Cov.: 31 AF XY: 0.0520 AC XY: 3869AN XY: 74470
GnomAD4 genome
AF:
AC:
8271
AN:
152278
Hom.:
Cov.:
31
AF XY:
AC XY:
3869
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
41
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Schnyder crystalline corneal dystrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at